TTY Biopharm Company Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,924	2,521	2,773	2,621	2,357	2,222
Short-Term Investments	15.89	467.74	309.02	195.54	326.86	372.65
Cash & Short-Term Investments	2,940	2,989	3,082	2,817	2,684	2,595
Cash Growth	13.04%	-3.02%	9.41%	4.93%	3.44%	1.12%
Accounts Receivable	1,397	1,518	1,354	1,344	1,227	1,138
Other Receivables	93.43	36.46	23.18	28.81	29.68	13.62
Receivables	1,491	1,554	1,377	1,373	1,257	1,151
Inventory	1,392	1,389	1,270	1,096	1,039	955.01
Prepaid Expenses	92.28	-	-	79.02	49.89	46.96
Other Current Assets	515.07	76.88	64.58	6.36	5.37	1.15
Total Current Assets	6,430	6,009	5,793	5,370	5,035	4,749
Property, Plant & Equipment	2,143	2,199	2,246	2,287	2,433	2,519
Long-Term Investments	1,885	2,205	1,940	1,578	1,496	1,432
Goodwill	-	247.9	247.9	-	-	-
Other Intangible Assets	575.44	177.27	123.44	164.01	250.75	124.9
Long-Term Deferred Tax Assets	65.8	65.8	58.52	48.71	47.1	63.72
Other Long-Term Assets	725.93	444.8	453.25	426.94	337.89	407.19
Total Assets	11,826	11,348	10,863	9,875	9,601	9,296
Accounts Payable	247.62	270.78	326.16	294.66	289.4	187.27
Short-Term Debt	1,550	700	1,200	1,450	1,370	1,711
Current Portion of Long-Term Debt	143.15	500	400	-	418.85	407.91
Current Portion of Leases	8.81	8.35	0.93	5.86	3.92	7.62
Current Income Taxes Payable	288.11	323.68	228.8	156.97	149.52	150.39
Current Unearned Revenue	46.3	53.7	34.34	14.23	33.13	39.77
Other Current Liabilities	732.83	783.33	672.18	662.02	652.62	547.55
Total Current Liabilities	3,017	2,640	2,862	2,584	2,917	3,052
Long-Term Debt	400	-	100	400	9.6	4.15
Long-Term Leases	5.2	7.4	10.2	3.05	3.04	14.16
Pension & Post-Retirement Benefits	-	17.01	17.54	27.4	40.81	52.6
Long-Term Deferred Tax Liabilities	363.19	363.19	359.24	318.75	305.44	260.52
Other Long-Term Liabilities	291.75	269.3	2.44	35.83	91.03	146.23
Total Liabilities	4,077	3,297	3,352	3,369	3,367	3,529
Common Stock	2,487	2,487	2,487	2,487	2,487	2,487
Additional Paid-In Capital	317.84	317.56	317.04	316.62	312.18	311.88
Retained Earnings	4,158	4,427	3,888	3,182	2,925	2,568
Comprehensive Income & Other	-6.64	7.18	58.69	-43.79	-64.78	-198.07
Total Common Equity	6,955	7,238	6,750	5,941	5,658	5,168
Minority Interest	793.2	812.93	760.49	564.8	574.86	599.38
Shareholders' Equity	7,749	8,051	7,511	6,506	6,233	5,767
Total Liabilities & Equity	11,826	11,348	10,863	9,875	9,601	9,296
Total Debt	2,107	1,216	1,711	1,859	1,805	2,145
Net Cash (Debt)	832.99	1,773	1,371	957.65	878.78	450
Net Cash Growth	115.65%	29.36%	43.11%	8.97%	95.28%	6.52%
Net Cash Per Share	3.34	7.11	5.50	3.84	3.53	1.81
Filing Date Shares Outstanding	249.34	248.65	248.65	248.65	248.65	248.65
Total Common Shares Outstanding	249.34	248.65	248.65	248.65	248.65	248.65
Working Capital	3,414	3,369	2,931	2,787	2,118	1,698
Book Value Per Share	27.90	29.11	27.15	23.89	22.76	20.78
Tangible Book Value	6,380	6,813	6,379	5,777	5,408	5,043
Tangible Book Value Per Share	25.59	27.40	25.65	23.23	21.75	20.28
Land	-	902.9	902.9	902.9	902.9	902.9
Buildings	-	1,495	1,479	1,461	1,432	1,420
Machinery	-	1,443	1,446	1,432	1,418	1,359
Construction In Progress	-	71.53	0.59	8.95	77.09	95